← All Jefferson Capital, INC / De filings

Jefferson Capital, INC / De Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
JCAP
Jefferson Capital, INC / De
Form 4: Jefferson Capital Executive Granted Stock Options
Mark Zellmann, President US Business Lines at Jefferson Capital, Inc., was granted 25,000 stock options with varying exercise prices and a ten-year expiration.
NASDAQ
JCAP
Jefferson Capital, INC / De
Form 4: Director John Oros Acquires Jefferson Capital Stock Options
Jefferson Capital Director John Oros acquired 50,000 stock options with varying exercise prices and a 10-year expiration, vesting annually.
NASDAQ
JCAP
Jefferson Capital, INC / De
Form 4: Jefferson Capital CEO Sells 385,000 Shares
Jefferson Capital, Inc.'s CEO and Director, David M. Burton, sold 385,000 shares of common stock at $20.5 per share as part of a secondary offering.
NASDAQ
JCAP
Jefferson Capital, INC / De
Form 4: JCF IV JCAP Holding Divests 11M JCAP Shares
JCF IV JCAP Holding L.P. and affiliated entities sold 11 million shares of Jefferson Capital, Inc. common stock in a secondary offering for approximately $215.9 million.
NASDAQ
JCAP
Jefferson Capital, INC / De
Form 4: J.C. Flowers Entities Reorganize Jefferson Capital Holdings
J.C. Flowers IV L.P. and JCF IV Coinvest JCAP L.P. transferred over 43 million shares of Jefferson Capital common stock to an affiliated entity as part of an internal reorganization.
NASDAQ
JCAP
Jefferson Capital, INC / De
Form 4: J.C. Flowers Entities Execute Significant Pre-Planned Sale of Jefferson Capital Shares
Key insiders, including J.C. Flowers IV L.P. and JCF IV Coinvest JCAP L.P., have completed a pre-planned sale of over 8.7 million shares of Jefferson Capital, Inc. common stock at $15 per share.
NASDAQ
JCAP
Jefferson Capital, INC / De
Form 4: Jefferson Capital CEO Reports Significant Share Transactions Post-IPO Reorganization
David M. Burton, CEO and President of Jefferson Capital, Inc., reported the acquisition of over 4.2 million shares in a pre-IPO reorganization and the subsequent sale of 424,296 shares to underwriters as part of the company's initial public offering.